BioPharmSignal logoBioPharmSignal

Biotech News

Intuitive Announces Expanded Indications for da Vinci SP

Intuitive (ISRG)IntuitiveFDA / regulatory

FDA clearance expands da Vinci SP indications to include inguinal hernia repair, cholecystectomy, and appendectomy SUNNYVALE, Calif. , Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today

Related news

ISRGIntuitive2026-01-26 14:15 EST

Da Vinci 5 Cleared for Cardiac Procedures

ISRGIntuitive2025-10-08 13:15 EST

Intuitive expands AI and advanced imaging integration in Ion Endoluminal System

View all latest news

Intuitive

Robotic-Assisted Surgery Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base. Da Vinci Platform The da Vinci surgical system enables surgeons to perform procedures through...

Recent company news

ISRGIntuitive2026-07-27 13:15 EST

Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options

ISRGIntuitive2026-07-23 13:05 EST

Intuitive Shares Vision for an AI-Enabled Future of Healthcare

ISRGIntuitive2026-07-16 20:05 EST

Intuitive Announces Second Quarter Earnings

ISRGIntuitive2026-05-28 20:30 EST

Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton

ISRGIntuitive2026-05-21 13:15 EST

Intuitive Announces Innovations to Advance Quintuple Aim

Stock data

Close
373.71 USD
Market cap
142.48B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States